Dr. Scott Owen's lab studies how neuromodulation can shape the activity of targeted cell types and circuits to guide behavior. Their goal is to understand how specialized physiology, connectivity, and cell-signaling support the diverse functions of individual neuronal cell types. How can a deeper understanding of these features guide future therapeutic interventions for neurological diseases including Autism, Obsessive-Compulsive Disorder, and Parkinson’s Disease?

Dr. Zachary Sellers is a pediatric physician-scientist striving to advance cystic fibrosis clinical care and translational research. Clinically, Dr. Sellers is focused on gastrointestinal manifestations of cystic fibrosis, developing diagnostic and therapeutic modalities to improve the gastrointestinal and liver health of those with cystic fibrosis. He also specializes in the clinical management of pediatric pancreatitis and am involved with the international INSPPIRE consortium to study pediatric pancreatitis.

The lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. Dr. Juyong Brian Kim's research laboratory is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events.

Dr. Joyce Teng, MD, PhD is a professor of dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). Dr. Teng received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 5 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology.

Dr. Jiajun Wu is an Assistant Professor of Computer Science at Stanford University, working on computer vision, machine learning, and computational cognitive science. Before joining Stanford, he was a Visiting Faculty Researcher at Google Research. Dr. Wu is affiliated with the Stanford Vision and Learning Lab (SVL) and the Stanford AI Lab (SAIL) and studies machine perception, reasoning, and its interaction with the physical world, drawing inspiration from human cognition.

Dr. Tobias Gerstenberg leads the Causality in Cognition Lab (http://cicl.stanford.edu). The CiCL studies the role of causality in our understanding of the world, and of each other. In their research, they formalize people’s mental models as computational models that yield quantitative predictions about a wide range of situations. To test these predictions, the lab uses a combination of large-scale online experiments, interactive experiments in the lab, and eye-tracking experiments.

Dr. Brian Suffoletto is a practicing emergency physician and NIH-funded investigator with expertise in designing and testing digital behavioral interventions. After clinical training in Emergency Medicine at the University of Pittsburgh, he completed a Master's of Science with a focus on Clinical Research. In 2014, he was awarded an NIAAA Career Development Award (K23) to develop skills and knowledge on addiction treatment and behavioral interventions.

Dr. Kevin Schulman was appointed as Professor of Medicine, Associate Chair of Business Development and Strategy in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Economics at Stanford’s Graduate School of Business in June, 2018. He is the Founding Faculty Director of the Master of Science in Clinical Informatics Management (MCiM) Program in the Stanford School of Medicine.

Dr. Kristan Staudenmayer received her medical degree at the University of Texas at Southwestern Medical School in 1999, and completed her residency in General Surgery at Parkland Hospital in 2006. During her post-graduate training, she conducted NIH T32-funded research at Harborview Hospital evaluating the effects of innate immunity on trauma. She obtained further training in Trauma and Surgical Critical at San Francisco General Hospital, completing her training in 2008. She was subsequently double-boarded in General Surgery and Surgical Critical Care.

Dr. Lisa Goldman Rosas is an Assistant Professor in the Department of Epidemiology and Population Health and the Department of Medicine, Division of Primary Care and Population Health at Stanford School of Medicine. An epidemiologist by training, Dr. Goldman Rosas’ research focuses on addressing disparities in chronic diseases such as diabetes, heart disease, depression, and cancer among racial/ethnic minority families. This research features rigorous quantitative and qualitative methodologies, participatory qualitative approaches, and shared leadership with patient and community partners.